Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22654 | 373 | 47.6 | 95% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
269 | 3 | CELL BIOLOGY//CAVEOLIN 1//CAVEOLAE | 44007 |
536 | 2 | X LINKED AGAMMAGLOBULINEMIA//BTK//SH2 DOMAIN | 14793 |
22654 | 1 | VAV//VAV1//VAV PROTO ONCOGENE | 373 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VAV | authKW | 2517403 | 17% | 50% | 62 |
2 | VAV1 | authKW | 1637250 | 8% | 67% | 30 |
3 | VAV PROTO ONCOGENE | authKW | 245590 | 1% | 100% | 3 |
4 | VAV3 | authKW | 210499 | 2% | 43% | 6 |
5 | VAV2 | authKW | 201499 | 2% | 31% | 8 |
6 | GDP GTP EXCHANGE FACTORS | authKW | 184191 | 1% | 75% | 3 |
7 | HUBERT H HUMPHREY EXPT MED CANC | address | 172915 | 3% | 16% | 13 |
8 | APL DERIVED CELLS | authKW | 163727 | 1% | 100% | 2 |
9 | SLP76 | authKW | 163727 | 1% | 100% | 2 |
10 | VAV FAMILY | authKW | 163727 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 2717 | 44% | 0% | 163 |
2 | Biochemistry & Molecular Biology | 1100 | 46% | 0% | 171 |
3 | Immunology | 544 | 20% | 0% | 73 |
4 | Oncology | 513 | 21% | 0% | 77 |
5 | Hematology | 184 | 8% | 0% | 28 |
6 | Medicine, Research & Experimental | 120 | 8% | 0% | 29 |
7 | Genetics & Heredity | 113 | 9% | 0% | 32 |
8 | Biophysics | 28 | 4% | 0% | 16 |
9 | Biochemical Research Methods | 9 | 3% | 0% | 10 |
10 | Cell & Tissue Engineering | 9 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HUBERT H HUMPHREY EXPT MED CANC | 172915 | 3% | 16% | 13 |
2 | INVEST CANC | 111891 | 8% | 5% | 29 |
3 | UNIT SINGLE MOL IMMUNOIMAGING | 109150 | 1% | 67% | 2 |
4 | MOL IMMUNOL PROGRAMME | 106935 | 2% | 15% | 9 |
5 | BIOL MOL CELULAR CANC | 88229 | 6% | 5% | 21 |
6 | ADV TECHNOL THER IES LTTA | 81863 | 0% | 100% | 1 |
7 | BIOIBER | 81863 | 0% | 100% | 1 |
8 | BIOL MOL CELULAR CANC IBSAL | 81863 | 0% | 100% | 1 |
9 | BIOL ULTRASTRUCT NOYAU | 81863 | 0% | 100% | 1 |
10 | BRIGHAM WOMENS HOSP MED EXPTL MED | 81863 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENE | 2812 | 7% | 0% | 25 |
2 | CRITICAL REVIEWS IN ONCOGENESIS | 2496 | 1% | 2% | 2 |
3 | CELLULAR SIGNALLING | 1866 | 3% | 0% | 10 |
4 | MOLECULAR AND CELLULAR BIOLOGY | 1599 | 6% | 0% | 21 |
5 | CELL GROWTH & DIFFERENTIATION | 924 | 1% | 0% | 4 |
6 | SCIENCE SIGNALING | 841 | 1% | 0% | 4 |
7 | JOURNAL OF EXPERIMENTAL MEDICINE | 793 | 3% | 0% | 11 |
8 | JOURNAL OF BIOLOGICAL CHEMISTRY | 658 | 10% | 0% | 36 |
9 | M S-MEDECINE SCIENCES | 606 | 1% | 0% | 5 |
10 | NATURE IMMUNOLOGY | 587 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VAV | 2517403 | 17% | 50% | 62 | Search VAV | Search VAV |
2 | VAV1 | 1637250 | 8% | 67% | 30 | Search VAV1 | Search VAV1 |
3 | VAV PROTO ONCOGENE | 245590 | 1% | 100% | 3 | Search VAV+PROTO+ONCOGENE | Search VAV+PROTO+ONCOGENE |
4 | VAV3 | 210499 | 2% | 43% | 6 | Search VAV3 | Search VAV3 |
5 | VAV2 | 201499 | 2% | 31% | 8 | Search VAV2 | Search VAV2 |
6 | GDP GTP EXCHANGE FACTORS | 184191 | 1% | 75% | 3 | Search GDP+GTP+EXCHANGE+FACTORS | Search GDP+GTP+EXCHANGE+FACTORS |
7 | APL DERIVED CELLS | 163727 | 1% | 100% | 2 | Search APL+DERIVED+CELLS | Search APL+DERIVED+CELLS |
8 | SLP76 | 163727 | 1% | 100% | 2 | Search SLP76 | Search SLP76 |
9 | VAV FAMILY | 163727 | 1% | 100% | 2 | Search VAV+FAMILY | Search VAV+FAMILY |
10 | VAV3 ONCOGENE | 163727 | 1% | 100% | 2 | Search VAV3+ONCOGENE | Search VAV3+ONCOGENE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KATZAV, S , (2015) VAV1: A DR. JEKYLL AND MR. HYDE PROTEIN - GOOD FOR THE HEMATOPOIETIC SYSTEM, BAD FOR CANCER.ONCOTARGET. VOL. 6. ISSUE 30. P. 28731 -28742 | 72 | 67% | 1 |
2 | TYBULEWICZ, VL , (2005) VAV-FAMILY PROTEINS IN T-CELL SIGNALLING.CURRENT OPINION IN IMMUNOLOGY. VOL. 17. ISSUE 3. P. 267-274 | 48 | 72% | 211 |
3 | LAZER, G , KATZAV, S , (2011) GUANINE NUCLEOTIDE EXCHANGE FACTORS FOR RHOGTPASES: GOOD THERAPEUTIC TARGETS FOR CANCER THERAPY?.CELLULAR SIGNALLING. VOL. 23. ISSUE 6. P. 969 -979 | 64 | 38% | 55 |
4 | KATZAV, S , (2007) FLESH AND BLOOD: THE STORY OF VAV1, A GENE THAT SIGNALS IN HEMATOPOLETIC CELLS BUT CAN BE TRANSFORMING IN HUMAN MALIGNANCIES.CANCER LETTERS. VOL. 255. ISSUE 2. P. 241-254 | 63 | 49% | 17 |
5 | TURNER, M , BILLADEAU, DD , (2002) VAV PROTEINS AS SIGNAL INTEGRATORS FOR MULTI-SUBUNIT IMMUNE-RECOGNITION RECEPTORS.NATURE REVIEWS IMMUNOLOGY. VOL. 2. ISSUE 7. P. 476-486 | 55 | 51% | 207 |
6 | BUSTELO, XR , (2000) REGULATORY AND SIGNALING PROPERTIES OF THE VAV FAMILY.MOLECULAR AND CELLULAR BIOLOGY. VOL. 20. ISSUE 5. P. 1461-1477 | 60 | 36% | 375 |
7 | BARREIRA, M , FABBIANO, S , COUCEIRO, JR , TORREIRA, E , MARTINEZ-TORRECUADRADA, JL , MONTOYA, G , LLORCA, O , BUSTELO, XR , (2014) THE C-TERMINAL SH3 DOMAIN CONTRIBUTES TO THE INTRAMOLECULAR INHIBITION OF VAV FAMILY PROTEINS.SCIENCE SIGNALING. VOL. 7. ISSUE 321. P. - | 37 | 59% | 2 |
8 | TYBULEWICZ, VLJ , ARDOUIN, L , PRISCO, A , REYNOLDS, LF , (2003) VAV1: A KEY SIGNAL TRANSDUCER DOWNSTREAM OF THE TCR.IMMUNOLOGICAL REVIEWS. VOL. 192. ISSUE 1. P. 42-52 | 48 | 54% | 75 |
9 | YIN, J , WAN, YJ , LI, SY , DU, MJ , ZHANG, CZ , ZHOU, XL , CAO, YJ , (2011) THE DISTINCT ROLE OF GUANINE NUCLEOTIDE EXCHANGE FACTOR VAV1 IN BCL-2 TRANSCRIPTION AND APOPTOSIS INHIBITION IN JURKAT LEUKEMIA T CELLS.ACTA PHARMACOLOGICA SINICA. VOL. 32. ISSUE 1. P. 99-107 | 30 | 71% | 3 |
10 | RAZANADRAKOTO, L , CORMIER, F , LAURIENTE, V , DONDI, E , GARDANO, L , KATZAV, S , GUITTAT, L , VARIN-BLANK, N , (2015) MUTATION OF VAV1 ADAPTOR REGION REVEALS A NEW ONCOGENIC ACTIVATION.ONCOTARGET. VOL. 6. ISSUE 4. P. 2524 -2538 | 32 | 58% | 2 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 13788 | SLP 76//ADAP//SECT LYMPHOCYTE SIGNALING |
2 | 1558 | RHO GTPASES//TIAM1//RHOB |
3 | 36304 | SWAP 70//SWITCH ASSOCIATED PROTEIN 70//DEF6 |
4 | 4230 | IMMUNOLOGICAL SYNAPSE//LYMPHOCYTE INTERACT//PROGRAM MOL PATHOGENESIS |
5 | 14390 | CBL//CBL B//C CBL |
6 | 18972 | SYK//SPLEEN TYROSINE KINASE//FOSTAMATINIB |
7 | 12290 | SH3 DOMAIN//SH2 DOMAIN//GRB2 |
8 | 15482 | BCL10//PKC THETA//CARMA3 |
9 | 30657 | KBG SYNDROME//AARSKOG SCOTT SYNDROME//FGD1 |
10 | 4882 | P56LCK//LCK//LCK INHIBITOR |